A. Barreto, A. Alexandrov, P. Lyden
Mar 1, 2012
Citations
1
Influential Citations
89
Citations
Quality indicators
Journal
Stroke
Abstract
Background and Purpose Argatroban is a direct thrombin inhibitor that safely augments recanalization achieved by tPA in animal stroke models. The Argatroban tPA Stroke Study was an open-label, pilot safety study of tPA plus Argatroban in patients with ischemic stroke due to proximal intracranial occlusion.